The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid.
If you have already subscribed please login.
If you have any technical issues please email tech support.
AstraZeneca, Seroquel, Hexal, drug formulation, dosage
